English

OMNI BIO PHARMACEUTICAL, INC.

EDGAR

Quarterly report (10-Q) · filed 2015-02-17

41 filing records in this dataset, filed from 2007-03-29 to 2015-02-17. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 852 thousand iso4217-usd 2014-12-31 Source
Exact value

852372 iso4217-usd
Long-term debt including current maturities: Not available
Shares outstanding: 40.2 million xbrli-shares 2014-12-31 Source
Exact value

40205880 xbrli-shares

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-02-17.

Financial data available through: 2014-03-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 9 of 11 periods available· newest 2014-03-31
Net income: 11 of 11 periods available· newest 2014-03-31
Operating cash flow: 9 of 11 periods available· newest 2014-03-31
Capital expenditure: 3 of 11 periods available· newest 2010-03-31
Total assets: Multiple units; comparison withheld· newest 2014-03-31
Total liabilities: Multiple units; comparison withheld· newest 2014-03-31
Current assets: Multiple units; comparison withheld· newest 2014-03-31
Current liabilities: Multiple units; comparison withheld· newest 2014-03-31
Cash and cash equivalents: Multiple units; comparison withheld· newest 2014-03-31
long term debt: No compatible figures in this window
Shares outstanding: Multiple units; comparison withheld· newest 2014-03-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 4.94 million

Prior period

−USD 7.45 million

2012-04-01 – 2013-03-31
Current period

−USD 2.52 million

2013-04-01 – 2014-03-31

Exact inputs and evidence

-2516641 − -7454623 = 4937982 USD

-7454623 USD · 2012-04-01 – 2013-03-31
Inspect prior input Prior source
-2516641 USD · 2013-04-01 – 2014-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · OMNI BIO PHARMACEUTICAL, INC. · 2014-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Year-over-year change in Net income: 4937982 USD Concept: fundies:NetIncome Period: 2013-04-01 to 2014-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2516641 USD (2013-04-01 to 2014-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#236275 Filing: 000143774914011253 Input fundies:NetIncome: -7454623 USD (2012-04-01 to 2013-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#236400 Filing: 000143774914011253
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 270,798

Prior period

−USD 1.7 million

2012-04-01 – 2013-03-31
Current period

−USD 1.43 million

2013-04-01 – 2014-03-31

Exact inputs and evidence

-1433250 − -1704048 = 270798 USD

-1704048 USD · 2012-04-01 – 2013-03-31
Inspect prior input Prior source
-1433250 USD · 2013-04-01 – 2014-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · OMNI BIO PHARMACEUTICAL, INC. · 2014-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Year-over-year change in Operating cash flow: 270798 USD Concept: fundies:OperatingCashFlow Period: 2013-04-01 to 2014-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1433250 USD (2013-04-01 to 2014-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#316996 Filing: 000143774914011253 Input fundies:OperatingCashFlow: -1704048 USD (2012-04-01 to 2013-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#317179 Filing: 000143774914011253
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2006-04-01 – 2007-03-31	−USD 1.1 million Exact value Exact value: -1100673 USD 2006-04-01 – 2007-03-31: -1100673 USD Inspect Net Income Open source Share or cite Citation for Net Income · OMNI BIO PHARMACEUTICAL, INC. · 2007-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Net Income: -1100673 USD Concept: fundies:NetIncome Period: 2006-04-01 to 2007-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ANetIncome&period=2007-03-31&surface=latest&period_type=duration&start=2006-04-01&unit=USD&dimensions= Input fundies:NetIncome: -1100673 USD (2006-04-01 to 2007-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#245895 Filing: 000143774914011253 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 60,611 Exact value Exact value: -60611 USD 2007-01-01 – 2007-12-31: -60611 USD Inspect Net Income Open source Share or cite Citation for Net Income · OMNI BIO PHARMACEUTICAL, INC. · 2007-12-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Net Income: -60611 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -60611 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0001079974-09-000155.txt#4947 The citation records this snapshot. The page link may show a newer release later.	−USD 56,612 Exact value Exact value: -56612 USD 2007-01-01 – 2007-12-31: -56612 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OMNI BIO PHARMACEUTICAL, INC. · 2007-12-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Operating Cash Flow: -56612 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -56612 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0001079974-09-000155.txt#5079 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2007-04-01 – 2008-03-31	−USD 1.81 million Exact value Exact value: -1812567 USD 2007-04-01 – 2008-03-31: -1812567 USD Inspect Net Income Open source Share or cite Citation for Net Income · OMNI BIO PHARMACEUTICAL, INC. · 2008-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Net Income: -1812567 USD Concept: fundies:NetIncome Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ANetIncome&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:NetIncome: -1812567 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#253283 Filing: 000143774914011253 The citation records this snapshot. The page link may show a newer release later.	−USD 576,236 Exact value Exact value: -576236 USD 2007-04-01 – 2008-03-31: -576236 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OMNI BIO PHARMACEUTICAL, INC. · 2008-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Operating Cash Flow: -576236 USD Concept: fundies:OperatingCashFlow Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3AOperatingCashFlow&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -576236 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0000950123-10-102605.txt#15616 The citation records this snapshot. The page link may show a newer release later.	USD 2,953 Exact value Exact value: 2953 USD 2007-04-01 – 2008-03-31: 2953 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OMNI BIO PHARMACEUTICAL, INC. · 2008-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Capital Expenditure: 2953 USD Concept: fundies:CapitalExpenditure Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ACapitalExpenditure&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2953 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0000950123-10-102605.txt#15711 The citation records this snapshot. The page link may show a newer release later.	−USD 579,189 Calculation and evidence -576236 − 2953 USD Exact free cash flow: -579189 USD 2007-04-01 – 2008-03-31: -576236 USD · Inspect Operating Cash Flow · Source 2007-04-01 – 2008-03-31: 2953 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OMNI BIO PHARMACEUTICAL, INC. · 2008-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Free cash flow: -579189 USD Concept: free-cash-flow Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -576236 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0000950123-10-102605.txt#15616 Input fundies:CapitalExpenditure: 2953 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0000950123-10-102605.txt#15711 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 74,794 Exact value Exact value: -74794 USD 2008-01-01 – 2008-12-31: -74794 USD Inspect Net Income Open source Share or cite Citation for Net Income · OMNI BIO PHARMACEUTICAL, INC. · 2008-12-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Net Income: -74794 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -74794 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0001079974-09-000155.txt#4947 The citation records this snapshot. The page link may show a newer release later.	−USD 54,101 Exact value Exact value: -54101 USD 2008-01-01 – 2008-12-31: -54101 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OMNI BIO PHARMACEUTICAL, INC. · 2008-12-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Operating Cash Flow: -54101 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -54101 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0001079974-09-000155.txt#5079 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2008-04-01 – 2009-03-31	−USD 4.54 million Exact value Exact value: -4544521 USD 2008-04-01 – 2009-03-31: -4544521 USD Inspect Net Income Open source Share or cite Citation for Net Income · OMNI BIO PHARMACEUTICAL, INC. · 2009-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Net Income: -4544521 USD Concept: fundies:NetIncome Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ANetIncome&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:NetIncome: -4544521 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#264302 Filing: 000143774914011253 The citation records this snapshot. The page link may show a newer release later.	−USD 56,513 Exact value Exact value: -56513 USD 2008-04-01 – 2009-03-31: -56513 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OMNI BIO PHARMACEUTICAL, INC. · 2009-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Operating Cash Flow: -56513 USD Concept: fundies:OperatingCashFlow Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3AOperatingCashFlow&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -56513 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0000950123-10-102605.txt#15616 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2008-04-01 – 2009-03-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OMNI BIO PHARMACEUTICAL, INC. · 2009-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ACapitalExpenditure&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0000950123-10-102605.txt#15711 The citation records this snapshot. The page link may show a newer release later.	−USD 56,513 Calculation and evidence -56513 − 0 USD Exact free cash flow: -56513 USD 2008-04-01 – 2009-03-31: -56513 USD · Inspect Operating Cash Flow · Source 2008-04-01 – 2009-03-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OMNI BIO PHARMACEUTICAL, INC. · 2009-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Free cash flow: -56513 USD Concept: free-cash-flow Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -56513 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0000950123-10-102605.txt#15616 Input fundies:CapitalExpenditure: 0 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0000950123-10-102605.txt#15711 The citation records this snapshot. The page link may show a newer release later.
2010 2009-04-01 – 2010-03-31	−USD 15.48 million Exact value Exact value: -15478884 USD 2009-04-01 – 2010-03-31: -15478884 USD Inspect Net Income Open source Share or cite Citation for Net Income · OMNI BIO PHARMACEUTICAL, INC. · 2010-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Net Income: -15478884 USD Concept: fundies:NetIncome Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ANetIncome&period=2010-03-31&surface=latest&period_type=duration&start=2009-04-01&unit=USD&dimensions= Input fundies:NetIncome: -15478884 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#276713 Filing: 000143774914011253 The citation records this snapshot. The page link may show a newer release later.	−USD 1.79 million Exact value Exact value: -1793869 USD 2009-04-01 – 2010-03-31: -1793869 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OMNI BIO PHARMACEUTICAL, INC. · 2010-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Operating Cash Flow: -1793869 USD Concept: fundies:OperatingCashFlow Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3AOperatingCashFlow&period=2010-03-31&surface=latest&period_type=duration&start=2009-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1793869 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0000950123-10-102605.txt#15616 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2009-04-01 – 2010-03-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OMNI BIO PHARMACEUTICAL, INC. · 2010-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ACapitalExpenditure&period=2010-03-31&surface=latest&period_type=duration&start=2009-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0000950123-10-102605.txt#15711 The citation records this snapshot. The page link may show a newer release later.	−USD 1.79 million Calculation and evidence -1793869 − 0 USD Exact free cash flow: -1793869 USD 2009-04-01 – 2010-03-31: -1793869 USD · Inspect Operating Cash Flow · Source 2009-04-01 – 2010-03-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OMNI BIO PHARMACEUTICAL, INC. · 2010-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Free cash flow: -1793869 USD Concept: free-cash-flow Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1793869 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0000950123-10-102605.txt#15616 Input fundies:CapitalExpenditure: 0 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/0000950123-10-102605.txt#15711 The citation records this snapshot. The page link may show a newer release later.
2011 2010-04-01 – 2011-03-31	−USD 8.23 million Exact value Exact value: -8225477 USD 2010-04-01 – 2011-03-31: -8225477 USD Inspect Net Income Open source Share or cite Citation for Net Income · OMNI BIO PHARMACEUTICAL, INC. · 2011-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Net Income: -8225477 USD Concept: fundies:NetIncome Period: 2010-04-01 to 2011-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ANetIncome&period=2011-03-31&surface=latest&period_type=duration&start=2010-04-01&unit=USD&dimensions= Input fundies:NetIncome: -8225477 USD (2010-04-01 to 2011-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#282458 Filing: 000143774914011253 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2012 2011-04-01 – 2012-03-31	−USD 5.4 million Exact value Exact value: -5395492 USD 2011-04-01 – 2012-03-31: -5395492 USD Inspect Net Income Open source Share or cite Citation for Net Income · OMNI BIO PHARMACEUTICAL, INC. · 2012-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Net Income: -5395492 USD Concept: fundies:NetIncome Period: 2011-04-01 to 2012-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ANetIncome&period=2012-03-31&surface=latest&period_type=duration&start=2011-04-01&unit=USD&dimensions= Input fundies:NetIncome: -5395492 USD (2011-04-01 to 2012-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#285676 Filing: 000143774914011253 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2013 2012-04-01 – 2013-03-31	−USD 7.45 million Exact value Exact value: -7454623 USD 2012-04-01 – 2013-03-31: -7454623 USD Inspect Net Income Open source Share or cite Citation for Net Income · OMNI BIO PHARMACEUTICAL, INC. · 2013-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Net Income: -7454623 USD Concept: fundies:NetIncome Period: 2012-04-01 to 2013-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ANetIncome&period=2013-03-31&surface=latest&period_type=duration&start=2012-04-01&unit=USD&dimensions= Input fundies:NetIncome: -7454623 USD (2012-04-01 to 2013-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#236400 Filing: 000143774914011253 The citation records this snapshot. The page link may show a newer release later.	−USD 1.7 million Exact value Exact value: -1704048 USD 2012-04-01 – 2013-03-31: -1704048 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OMNI BIO PHARMACEUTICAL, INC. · 2013-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Operating Cash Flow: -1704048 USD Concept: fundies:OperatingCashFlow Period: 2012-04-01 to 2013-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3AOperatingCashFlow&period=2013-03-31&surface=latest&period_type=duration&start=2012-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1704048 USD (2012-04-01 to 2013-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#317179 Filing: 000143774914011253 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2013-04-01 – 2014-03-31	−USD 2.52 million Exact value Exact value: -2516641 USD 2013-04-01 – 2014-03-31: -2516641 USD Inspect Net Income Open source Share or cite Citation for Net Income · OMNI BIO PHARMACEUTICAL, INC. · 2014-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Net Income: -2516641 USD Concept: fundies:NetIncome Period: 2013-04-01 to 2014-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3ANetIncome&period=2014-03-31&surface=latest&period_type=duration&start=2013-04-01&unit=USD&dimensions= Input fundies:NetIncome: -2516641 USD (2013-04-01 to 2014-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#236275 Filing: 000143774914011253 The citation records this snapshot. The page link may show a newer release later.	−USD 1.43 million Exact value Exact value: -1433250 USD 2013-04-01 – 2014-03-31: -1433250 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OMNI BIO PHARMACEUTICAL, INC. · 2014-03-31 OMNI BIO PHARMACEUTICAL, INC. (edgar:1389870) Operating Cash Flow: -1433250 USD Concept: fundies:OperatingCashFlow Period: 2013-04-01 to 2014-03-31 Values: Latest reported Published: 2026-11-02T19:30:20Z Snapshot: a5316f86360c0b47b6b9735e364ac2faffeace42269fe55b639a93150e928137 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1389870/explain?concept=fundies%3AOperatingCashFlow&period=2014-03-31&surface=latest&period_type=duration&start=2013-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1433250 USD (2013-04-01 to 2014-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1389870/000143774914011253/ombp-20140331.xml#316996 Filing: 000143774914011253 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

41 filings · 1,103 latest values · 1,103 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001389870, 1389870, edgar:1389870

Also known as Across America Financial Services, Inc., OMNI BIO PHARMACEUTICAL, INC.

OMNI BIO PHARMACEUTICAL, INC.

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation